KRXAX Fees and Costs — Kinetics Medical Fund, Advisor Class A
Data updated: 2023-03-16
The net expense ratio is 1.64%: a 1.25% management fee, a 0.50% 12b-1 fee plus 0.68% other expenses, less a 0.79% fee waiver. This share class carries a maximum front-end sales load of 5.75% and a redemption fee of 2.00%. Portfolio turnover was 1%.
KRXAX Fees and Expenses
Annual operating expenses and sales charges of KRXAX. Prospectus, as of April 30, 2022.
| Annual operating expenses | |
|---|---|
| Management fee | 1.25% |
| 12b-1 fee | 0.50% |
| Other expenses | 0.68% |
| Gross expense ratio | 2.43% |
| Fee waiver | −0.79% |
| Net expense ratio | 1.64% |
| Sales charges | |
|---|---|
| Max front load | 5.75% |
| Max deferred load | 0.00% |
| Redemption fee | 2.00% |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
KRXAX Costs Over Time
On $10,000 invested in KRXAX, assuming 5% a year before costs, total costs come to $1,688 over 5 years, cutting the return by 2.94% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $575 | $575 | $575 |
| Fund expenses (net expense ratio 1.64%) | $162 | $503 | $866 |
| Lost growth on money paid in costs | $29 | $116 | $247 |
| Total costs | $766 | $1,194 | $1,688 |
| Value after costs | $9,734 | $10,383 | $11,074 |
| Impact on return, per year | 7.66% | 3.74% | 2.94% |
KRXAX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending December 31, 2022.
- Explicit cost rate (commissions ÷ average net assets): —
- Total broker commissions: —
- Bought from dealers (principal trades, not a cost): —
- Portfolio turnover (prospectus): 1%
- Securities lending: none during the year
KRXAX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| BNY MELLON CAPITAL MARKETS LLC | $240 | 53.33% |
| WEEDEN & CO.L.P. | $160 | 35.56% |
| VIRTU ITG LLC | $50 | 11.11% |
Kinetics Medical Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| MEDRX | No Load Class | 1.39% | — |
| KRXAX | Advisor Class A | 1.64% | 5.75% |
| KRXCX | Advisor Class C | 2.14% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.